-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Overweight on Gilead Sciences, Raises Price Target to $170

Benzinga·10/07/2026 16:35:23
Listen to the news
JP Morgan analyst Chris Schott maintains Gilead Sciences (NASDAQ:GILD) with a Overweight and raises the price target from $160 to $170.